<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">18593787</PMID>
<DateCompleted>
<Year>2008</Year>
<Month>08</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1535-7228</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>165</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2008</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of psychiatry</Title>
<ISOAbbreviation>Am J Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia.</ArticleTitle>
<Pagination>
<MedlinePgn>813-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1176/appi.ajp.2008.07111823</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ghaznavi</LastName>
<ForeName>Sharmin</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Yale University, 34 Park St., New Haven, CT 06519, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakic</LastName>
<ForeName>Marina</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rao</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hu</LastName>
<ForeName>Jian</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brewer</LastName>
<ForeName>Judson A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hannestad</LastName>
<ForeName>Jonas</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bhagwagar</LastName>
<ForeName>Zubin</ForeName>
<Initials>Z</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>5T32GM07205</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Psychiatry</MedlineTA>
<NlmUniqueID>0370512</NlmUniqueID>
<ISSNLinking>0002-953X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>J60AR2IKIC</RegistryNumber>
<NameOfSubstance UI="D003024">Clozapine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>L6UH7ZF8HC</RegistryNumber>
<NameOfSubstance UI="D018967">Risperidone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Am J Psychiatry. 2008 Dec;165(12):1611; author reply 1611-2</RefSource>
<PMID Version="1">19047335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Am J Psychiatry. 2010 May;167(5):602-3</RefSource>
<PMID Version="1">20439404</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014150">Antipsychotic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003024">Clozapine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004351">Drug Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009503">Neutropenia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012008">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018967">Risperidone</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012563">Schizophrenia, Paranoid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2008</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2008</Year>
<Month>8</Month>
<Day>2</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2008</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">18593787</ArticleId>
<ArticleId IdType="pii">165/7/813</ArticleId>
<ArticleId IdType="doi">10.1176/appi.ajp.2008.07111823</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>